Company Profile
Everis Medical is a US-based manufacturer of specialty medical devices, headquartered in Kalamazoo, Michigan, USA. Founded in 2019 as C2Dx by Kevin McLeod and Plymouth Growth Partners, the company rebranded to Everis Medical in May 2025 and operates as an independent, privately-held entity backed by Shore Capital Partners (since September 2023), serving otolaryngologists, head and neck surgeons, and airway specialists across the United States, Canada, and select international markets.
Core Products ＆ Technologies
ENT ＆ Head ＆ Neck Surgery Systems
• Biodesign® Otologic Repair Grafts: Porcine small intestinal submucosal grafts for tympanic membrane perforation repair and otologic tissue remodeling
• Duraplasty Grafts: Soft tissue grafts for dural repair and reconstruction in cranial and spinal procedures
• Sialendoscopy Instruments and Accessories: Minimally invasive salivary duct access and interventional suite including Kolenda Salivary Access Introducer Set, NCircle® and NGage® nitinol stone extractors, Advance® salivary duct balloon catheter, SialoCath® duct catheter, and Cook Sphere® inflation device; acquired from Cook Medical in January 2024
Airway ＆ Thoracic Management
• Hood Laboratories Airway Portfolio: T-Tubes for tracheal stenosis, rhinology and laryngology devices, thoracic surgery instruments, interventional pulmonology tools, and speech therapy devices; acquired May 2026
• Hercules 100 Transnasal Esophagoscopy (TNE): Office-based transnasal esophagoscopy system for direct visualization of the esophagus
Surgical ＆ Critical Care Support
• Shaw Scalpel: Electrosurgical scalpel system for precise cutting and coagulation; acquired from Hemostatix
• STIC Intra-Compartmental Pressure Monitor: Diagnostic device for measuring compartment pressures in acute and trauma settings; acquired from Stryker
• T/Pump Localized Temperature Therapy System: Patient warming and cooling device for localized temperature management; acquired from Stryker
Market Position ＆ Certifications
Everis Medical holds a specialized, acquisition-driven position in the global ENT and head ＆ neck surgery device market, competing with Medtronic and Olympus in otolaryngology surgical instruments and endoscopy. Key strengths include:
• Acquisition-driven growth: Five strategic product line acquisitions since 2019, building a diversified niche portfolio
• Revitalization expertise: Proven track record of acquiring underserved technologies and expanding market penetration through dedicated sales and clinical support
• Regulatory heritage: Products maintain established FDA clearances and CE markings inherited from original manufacturers (Cook Medical, Stryker, Hemostatix)
• Distribution expansion: Exclusive Canadian distribution partnership with Southmedic effective August 2025, extending reach to hospitals and surgical centers nationwide
Corporate Timeline
2019 — Founded as C2Dx in Kalamazoo, MI by Kevin McLeod and Plymouth Growth Partners to acquire and revitalize niche medical device technologies
Prior to 2024 — Acquired Shaw Scalpel (Hemostatix), STIC Pressure Monitor (Stryker), and T/Pump Temperature Therapy System (Stryker)
2023 — Shore Capital Partners completed partnership with C2Dx
2024 — Acquired Otolaryngology / Head ＆ Neck Surgery product line from Cook Medical, adding sialendoscopy, otologic grafts, and duraplasty portfolios
2025 — Rebranded to Everis Medical; appointed Southmedic as exclusive Canadian distributor; debuted new branding at COSM 2025
2026 — Acquired Hood Laboratories (fifth acquisition), adding T-Tubes, airway, thoracic, and speech therapy devices
Target Markets ＆ Applications
• Otolaryngology and head ＆ neck surgery: Sialendoscopy for obstructive salivary disease, otologic repair for tympanic membrane perforation, and soft tissue grafting for cranial reconstruction
• Airway and thoracic management: Tracheal stenosis treatment, interventional pulmonology, and speech therapy devices for airway and thoracic specialists
• Outpatient and office-based procedures: Transnasal esophagoscopy and in-office sialendoscopy for minimally invasive diagnosis and treatment
Contact Information
Global Headquarters
Address: Kalamazoo, Michigan, USA
Parent Company
Everis Medical operates as an independent, privately-held entity with no publicly traded stock.
Investor: Shore Capital Partners (Chicago-based private equity)
Website: everismedical.com
Investor Relations: Private company; contact info@everismedical.com
